Title:Evaluation of a Method Based on Coherence in Aqueous Systems and Resonance-Based Isotherapeutic Remedy in the Treatment of Chronic Psoriasis Vulgaris
VOLUME: 15 ISSUE: 6
Author(s):Emilio Del Giudice, Anna De Filippis, Nicola Del Giudice, Marta Del Giudice, Immacolata d’Elia, Lorenza Iride, Ennio Menghi, Alberto Tedeschi, Valentina Cozza, Baroni Adone and Maria Antonietta Tufano
Affiliation:Department of Experimental Medicine, Section of Microbiology and Clinical Microbiology, Second University of Naples (SUN), via Luigi De Crecchio n° 7, 80138, Naples, Italy.
Keywords:Electrodynamic coherence, Isotherapeutic remedy, Osteopontin, Psoriasis, WHITE holographic bioresonance
method.
Abstract:Psoriasis is a chronic skin disorder that exhibits three main features: lymphocytic infiltration
into the dermis and epidermis, uncontrolled proliferation and abnormal differentiation of keratinocytes.
In this study we have evaluated the effect of treatment with WHITE Holographic Bioresonance Method
and a resonance-based isotherapeutic remedy on patients affected by chronic psoriasis vulgaris. The
WHITE Holographic Bioresonance Method is based on the principles of electrodynamic coherence. By exploiting the
phenomenon of bio-resonance, it uses a transfer plate to produce resonance- and light-based isotherapeutic coherent acqueous
remedies and gels that emit coherent oscillations which “imprint” the area of psoriasis-affected skin. Levels of
proinflammatory cytokines have been evaluated in the plasma of psoriatic patients treated with isotherapeutic remedies.
The obtained results demonstrate a positive effect on the natural course of the disease and matched the results obtained by
psoriatic patients treated with narrow band UVB. A significant reduction in plasma levels of cytokines involved in pathogenesis
of psoriasis has been observed. Our findings may suggest that WHITE Holographic Bioresonance method used in
combination with resonance-based isotherapeutic remedy could well be a new useful treatment option for patients with
limited psoriatic plaques.
